ACT-CSP for Family Caregivers of Palliative Care Patients

February 27, 2024 updated by: The Hong Kong Polytechnic University

An Acceptance and Commitment Therapy - Caregiver Support Program (ACT-CSP) for Family Caregivers of Patients Receiving Palliative Care: A Feasibility Study

The goal of the study is to test the feasibility, acceptability and preliminary efficacy of an acceptance and commitment therapy for supporting caregiver programme (ACT-CSP) on reduction of caregiver burden, anxiety and depressive symptoms and enhancement of caregiving self-efficacy, resilience and quality of life by ACT when compared to usual care, for caregivers of palliative care patients.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study will employ a pilot randomized controlled trial recruiting caregivers of palliative care patients to receive either a 3-week acceptance and commitment therapy for supporting caregiver programme (ACT-CSP) plus usual care (n = 15) or usual care only (n = 15). The components of acceptance and commitment therapy process will be emphasized in the intervention programme, which include perspective taking, self-as-context and defusion (i.e. recognizing worry thoughts as thoughts only), identifying values and acceptance of present-moment experience with respect to the values, and committed action. The ACT-CSP will be delivered by a trained ACT facilitator. Participants will be followed up at Week 6 and Week 8 after recruitment to collect data for assessing the study objectives.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged ≥ 18;
  • Self- or patient-identified as a family caregiver of an adult patient receiving palliative care at the study site
  • Have been taking care of the patient in the past 3 months;
  • Able to communicate in Cantonese at the time of recruitment;
  • Have access to internet and videoconferencing device such as mobile phone;
  • Have caregiver burden as measured by Caregiver Strain Index (CSI) ≥ 7.

Exclusion Criteria:

  • Mentally incompetent (Mini-Mental State Examination (MMSE) < 23),
  • Participating in regular psychosocial interventions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ACT-CSP
Three sessions of acceptance and commitment therapy.
The ACT treatment will consist of three 45 to 60-min weekly sessions to be delivered to the caregiver in an individual format via online videoconferencing application e.g. ZOOM or WhatsApp within 3 weeks. The ACT-CSP can be delivered via face-to-face on request. Each session has a specific content with pre-planned materials and mindfulness exercises and metaphors. Psychological-based homework will be assigned at the end of each session. The components of ACT process will be emphasized in the intervention programme, which include perspective taking, self-as-context and defusion (i.e. recognizing worry thoughts as thoughts only), identifying values and acceptance of present-moment experience with respect to the values, and committed action.
No Intervention: Usual Care
Usual treatment provided at the participating site.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Chinese version of the 13-item Caregiver Strain Index
Time Frame: Baseline, Week 6 and Week 8
Items are rated on a yes (1) or no (0) response, with the total score ranges from 0-13 and higher scores indicating higher caregiver burden
Baseline, Week 6 and Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Patient Health Questionnaire-4 (PHQ-4)
Time Frame: Baseline, Week 6 and Week 8
The scale scores range from 0 to 12, with higher scores indicating higher levels of anxiety and depression.
Baseline, Week 6 and Week 8
The Chinese version of the 18-item modified Caregiver Inventory
Time Frame: Baseline, Week 6 and Week 8
The scale covers 3 dimensions: Care of the Care Recipient (7 items), Managing information and Self-care (7 items), and Managing emotional interaction with care recipient (4 items). The first two dimensions have scores ranging from 7 to 63 while the last dimension has scores ranging from 4 to 36, with higher scores indicating higher levels of self-efficacy in that dimension.
Baseline, Week 6 and Week 8
The 10-item Chinese version of the Connor-Davidson Resilience Scale
Time Frame: Baseline, Week 6 and Week 8
The overall scores range 0-40, with higher scores indicating higher levels of resilience
Baseline, Week 6 and Week 8
The 10-item version of the Singapore caregiver quality of life
Time Frame: Baseline, Week 6 and Week 8
The overall scores range 0-40, with higher scores indicating higher levels of quality of life
Baseline, Week 6 and Week 8

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The 15-item Brief Experiential Avoidance Questionnaire
Time Frame: Baseline, Week and Week 8
The overall scores range 15-90, with higher scores indicating lower levels of psychological flexibility
Baseline, Week and Week 8
Satisfaction to the treatment received
Time Frame: Week 6
One item on a 0-10 VAS scale, with higher scores indicating higher levels of satisfaction.
Week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Doris YP Leung, The Hong Kong Polytechnic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2024

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

November 29, 2023

First Submitted That Met QC Criteria

January 14, 2024

First Posted (Actual)

January 24, 2024

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 27, 2024

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ACT PC Caregivers

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data are not readily shared because permission to use the data by other researchers has to seek approval from the ethical committee. Requests to access IPD should be directed to PI for further consideration and seeking approval from ethical committee.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caregiver Burden

Clinical Trials on ACT-CSP

3
Subscribe